Sensitivity analyses: censoring and nested case–control design
| Time from exposure | Adjusted HR ()/OR (95% CI) |
| Pneumonia (aHR)* | 1.1 (1.0 to 1.3) |
| Pneumonia (OR)† | 1.4 (1.2 to 1.7) |
| All-cause mortality (OR)‡ | 2.4 (1.9 to 2.9) |
*Analyses of long vs short oral corticosteroid (OCS) courses in all patients, censored prior to the second OCS course, 1-year follow-up. Analyses were adjusted for age, sex, inhaled corticosteroids, smoking status, calendar year, FEV1% predicted, Medical Research Council Dyspnoea Scale, body mass index, heart failure, atrial fibrillation, myocardial infarction, hypertension, diabetes mellitus, peripheral vascular disease, cerebrovascular disease, renal failure and depression.
†Estimated OR for pneumonia hospitalisation in a nested case–control design, 1 year before the index date. Matched on age, sex, FEV1% predicted and smoking.
‡Estimated OR for all-cause mortality in a nested case–control design, 1 year before the index date. Matched on age, sex, FEV1% predicted and smoking.